Biomarkers for use in integrin therapy applications
US-2022049301-A1 · Feb 17, 2022 · US
This page is not indexed by search engines while we improve data quality.
Violette Shelia M patents
Violette Shelia M is listed as an inventor on 12 patents in our database. Major assignees and classification codes are summarized below.
| Metric | Value |
|---|---|
| Inventor | Violette Shelia M |
| Total patents | 12 |
| First publication | Mar 26, 2015 |
| Latest publication | Feb 17, 2022 |
Notable patents
Publications ranked by popularity score, then publication date.
Biomarkers for use in integrin therapy applications
US-2020248257-A1 · Aug 6, 2020 · US
Anti-alpha V beta 6 antibodies and uses thereof
US-10035860-B2 · Jul 31, 2018 · US
Anti-alpha V beta 6 antibodies and uses thereof
US-10035859-B2 · Jul 31, 2018 · US
Humanized anti-alpha v beta 5 antibodies and uses thereof
US-2017362324-A1 · Dec 21, 2017 · US
Anti-ανβ6 antibodies
US-9745376-B2 · Aug 29, 2017 · US
Anti-alpha v beta 6 antibodies and uses thereof
US-2016031992-A1 · Feb 4, 2016 · US
Treatment and prevention of acute kidney injury using anti-alpha v beta 5 antibodies
US-2016017041-A1 · Jan 21, 2016 · US
Anti-alpha v beta 6 antibodies and uses thereof
US-2016017042-A1 · Jan 21, 2016 · US
Anti-alpha(v)beta(6) Antibodies
US-2015140609-A1 · May 21, 2015 · US
Recent patents
Latest publications not already listed above.
Anti-ανβ6 antibodies and uses thereof
US-8992924-B2 · Mar 31, 2015 · US
Biomarkers for use in integrin therapy applications
US-2015086570-A1 · Mar 26, 2015 · US
Major assignees
Companies most often associated with this inventor's publications.
| Assignee | Patents |
|---|---|
| Biogen Ma Inc | 9 |
| Univ California | 5 |
| Biogen Idec Inc | 3 |
| Violette Shelia M | 1 |
| Koopman Louise A | 1 |
Top CPC classifications
Most common classification codes across this inventor's patents.
| CPC | Patents |
|---|---|
| C07K2317/24 | 9 |
| C07K16/2839 | 9 |
| C07K2317/565 | 7 |
| G01N2333/70546 | 6 |
| C07K2317/76 | 6 |